In the present study, the distribution pattern and characteristics of cells containing Factor XIII subunit a (FXIII A) have been studied in benign and malignant lesions of human buccal mucosa. Tissues from four irritation fibromas and three squamous cell carcinomas were studied by means of double immunofluorescent staining techniques in which the detection of FXIII A was combined with a reaction with CD14 (recognizing a monocyte/macrophage differentiation marker antigen), Mac 387 (reacting with a special subset of macrophages), anti-HLA-DR, Ki-M7 (labelling phagocytosing macrophages) or Ki-67 (visualizing a nuclear antigen associated with cell proliferation) monoclonal antibodies. FXIII A was detected in cells of the connective tissue stroma in both benign and malignant buccal lesions. The number of these FXIII A-reactive cells (FXIII A+ cells) increased considerably in the tumour tissues, in particular in those surrounding tumour cell clusters. FXIII A+ cells scattered in the fibromatous tissues were spindle-shaped, whereas in the tumour stroma, large stellate cells predominated, and round cells were likewise labelled around blood vessels. FXIII A+ cells were labelled with CD14 and Ki-M7 in both fibromatous and tumoural buccal mucosa; however, they failed to show any reaction with Ki-67. FXIII A+ cells accumulated in the tumour stroma reacted for HLA-DR as well. These results indicate that in both the benign and malignant buccal lesions FXIII A is contained in a subpopulation of tissue macrophages, which represents a monocyte-derived (CD14+) and phagocytosing (Ki-M7+) cell population. The accumulation of the FXIII A+ cells in the tumour stroma is believed to be a result of direct migration from the circulating blood.(ABSTRACT TRUNCATED AT 250 WORDS)

Download full-text PDF

Source

Publication Analysis

Top Keywords

fxiii cells
20
benign malignant
16
malignant buccal
12
buccal lesions
12
tumour stroma
12
cells
10
fxiii
10
cells factor
8
factor xiii
8
xiii subunit
8

Similar Publications

Blood clots are complex structures composed of blood cells and proteins held together by the structural framework provided by an insoluble fibrin network. Factor (F)XIII is a protransglutaminase essential for stabilizing the fibrin network. Activated FXIII(a) introduces novel covalent crosslinks within and between fibrin and other plasma and cellular proteins, and thereby promotes fibrin biochemical and mechanical integrity.

View Article and Find Full Text PDF

Background: Germline haplodeficiency (RHD) is associated with thrombocytopenia, platelet dysfunction and predisposition to myeloid malignancies. Platelet expression profiling of a RHD patient showed decreased encoding for the A subunit of factor XIII, a transglutaminase that cross-links fibrin and induces clot stabilization. FXIII-A is synthesized by hematopoietic cells, megakaryocytes and monocytes.

View Article and Find Full Text PDF

Localization of Hemostasis Elements in Aspirated Coronary Thrombi at Different Stages of Evolution.

Int J Mol Sci

November 2024

Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.

Article Synopsis
  • The study investigates the structure and evolution of coronary thrombi in STEMI, focusing on the role of activated protein C (APC/PC) and factors like factor XIII (FXIII) and α2 plasmin inhibitor (α2-PI).
  • Histopathological analysis of thrombi from 24 male patients revealed that thrombus age (fresh, lytic, organized) affects the levels and distribution of APC/PC, FXIII, and α2-PI.
  • Key findings indicate that FXIII is highly co-localized with fibrin, while α2-PI increases during thrombus lysis, and NET markers are most prominent in the lytic phase, highlighting potential therapeutic strategies for STEMI.
View Article and Find Full Text PDF
Article Synopsis
  • - Platelet factor XIII-A (FXIII-A) is a significant protein in platelets, with over 80% remaining attached to platelets even after strong activation, while other proteins like tissue factor pathway inhibitor are released.
  • - The retention of FXIII-A during platelet activation is influenced by various factors including STIM1 signaling, microtubule changes, calpain activity, and RhoA activation, but it does not rely on the presence of fibrinogen or plasminogen.
  • - Despite being released, the FXIII-A found in the supernatant is cleaved and susceptible to degradation, whereas the FXIII-A remaining with the platelets is intact, indicating distinct biological roles for platelet-derived and plasma
View Article and Find Full Text PDF

Macrophages in CRSwNP: Do they deserve more attention?

Int Immunopharmacol

June 2024

School of Preclinical Medicine, Chengdu University, Chengdu, Sichuan, China. Electronic address:

Chronic rhinosinusitis (CRS) represents a heterogeneous disorder primarily characterized by the persistent inflammation of the nasal cavity and paranasal sinuses. The subtype known as chronic rhinosinusitis with nasal polyposis (CRSwNP) is distinguished by a significantly elevated recurrence rate and augmented challenges in the management of nasal polyps. The pathogenesis underlying this subtype remains incompletely understood.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!